The histone H3K27 methyltransferase EZH2 expression was up-regulated in CRC, which was predicted shorter survival and advanced stage implying that it could use to an indicator of clinical outcome in CRC patients [69, 70]. This evidence concerns the gene EZH2 and colorectal carcinoma.